Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1993-05-20
1995-10-03
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514654, 514649, 514328, A61K 31135
Patent
active
054552761
ABSTRACT:
Pharmaceutical compositions for treating psychiatric disorders are provided. The compositions include 2-phenylethylamine ("PEA") and at least one inhibitor of monoamine oxidase B. Methods for the treatment of psychiatric disorders, including depression, using the disclosed pharmaceutical compositions are also provided.
REFERENCES:
patent: 4421767, Palfreyman et al.
patent: 4705796 (1987-11-01), Hendry et al.
patent: 4880833 (1989-11-01), Knoll et al.
Birkmayer et al., Medline Abstrcts, No. 84187532, 1984.
Reynolds et al., Medline Abstracts, No. 79131749, 1978.
Mann et al., Medline Abstracts, No. 89087241, 1989.
Piccinin et al., Medline Abstracts, No. 90227672, 1990.
Liebowitz et al., Medline Abstracts, No. 85175264, 1985.
Timar et al., Chemical Abstracts, vol. 104, No. 23, Jun. 9, 1986, abstract no. 200153e.
Beck, et al., Beck Depression Inventory (Harper & Row Publishers, Inc. 1961).
Boulton, et al., Br. J. Pharmacol., 59:209-214 (1977).
DeLisi, et al., Psychiat. Res., 13:193-201 (1984).
Durden and Philips, J. Neurochem., 34:1725-1732 (1980).
Fischer, et al., Acta Physiol. Lat. Amer., 17:15-21 (1967).
Fischer, et al., Biol. Psychiat., 5:139-147 (1972).
Greenshaw, "B-phenylethylamines: A Functional Role at the Behavioral level," Neurobiology of the Trace Amines (Humana Press 1984).
Hamilton, Br. J. of Social and Clinical Psych., 6:278-296 (1967).
Hamilton, J. Neural. Surg. Psychiat., 23:56-61 (1960).
Inwang, et al., J. Neurochem., 20:1469-1473 (1973).
Jackson, J. Pharm. Pharmacol., 24:383-389 (1972).
Jackson and Temple, Comp. Gen. Pharmacol., 1:155-157 (1970).
Karoum, et al., Biol. Psychiat., 19:165-178 (1984).
Mann, et al., J. Clin. Psychopharmacol., 2:54-57 (1982).
Mann and Gershon, Life Sci., 26:877-882 (1980).
Mendis, et al., Psychopharmacol., 73:87-90 (1981).
Mosnaim, et al., Biol. Psychiat., 6:235-257 (1973).
Murphy, et al., "Phenylethylamine, Tyramine and Other Trace Amines in Pateints With Affective Disorders," Neurobiology of the Trace Amines, pp. 449-514 (1984).
Nakajima, et al., J. Pharmacol. Exptl. Therap., 143:319-325 (1964).
Philips and Boulton, J. Neurochem., 33:159-167 (1979).
Sabelli, "Clinical Antidepressant Effects of Selegiline and L-phenylalanine Support Mood-regualting Role for Brain 2-phenylethylamine," FASEB, 1991.
Sabelli, J. Clin. Psych., 52(3):137 (1991).
Sabelli, Proc. Amer. Psychiat. Assoc., New Research Program and Abstracts, New York, N.Y. May 12-17, 1990:146.
Sabelli, et al., Acta Physiol. Pol., 24:33-40 (1973).
Sabelli, et al., Biol. Psychiat., 3:273-280 (1971).
Sabelli, et al., FASEB, 3(4):A1186 (1989).
Sabelli, et al., J. Neuropsychiat., 1:37-39 (1989).
Sabelli, et al., Science, 220:1187-1188 (1983).
Sabelli and Giardina, "Amine Modulation of Affective Behavior," Chemical Modulation of Brain Function, pp. 225-259 (Raven Press 1973).
Sabelli and Mosnaim, Am. J. Psych., 131:695-699 (1974).
Varga, et al., Acta. Med. Acad. Sci. Hung., 23:289-295 (1967).
Borison, et al., Life Sci., 17:1331-1344 (1975).
Boulton, Prog. Neuro-Psychopharmacol. and Biol. Psychiat., 15:139-156 (1991).
Fawcett, et al., "CNS Amine Metabolites," Handbook of Psychiatric Diagnostic Procedures, vol. 1, Ch. 3, pp. 49-108 (R. C. W. Hall, ed., Spectrum Publications 1984).
Giardina, et al., Life Sci., 12:153-161 (1973).
Kravitz, et al., J. Am. Osteopathic Assoc., 8(1):119-123 (1984).
Paterson, et al., J. Neurochem., 55:1827-1837 (1990).
Sabelli, et al., Biol. Psychiat., 11:481-524 (1976).
Sabelli, et al., Nature, 248:144-145 (1974).
Sabelli, et al., "(-)--Trans--.DELTA..sup.9 --Tetrahydrocannabinol-Induced Increase in Brain 2-Phenylethylamine: Its Possible Role in the Behavioral Effects of Marijuana," Drug Addition: Neurobiology and Influences on Behavior, vol. 3, pp. 271-284 (1974).
Vasquez and Sabelli, "Electrophysiological Studies with .DELTA..sup.9 -Tetrahydrocannabinol," Drug Addiction: Neurobiology and Influences on Behavior, vol. 3, pp. 361-374 (J. M. Singh and H. Lal, eds., Stratton 1974).
Vasquez and Sabelli, Exptl. Neurology, 46:44-56 (1975).
Davis, et al., Prog. Neuro-Psychopharmacol. and Biol. Psychiat., 15:611-623 (1991).
Durden and Boulton, J. Neurochem., 38:1532-1536 (1982).
Faull, et al., Psychiat. Res., 30:111-118 (1989).
Gusovsky, et al., Anal. Biochem., 136:202-207 (1984).
Mizock, et al., Arch. Intern. Med., 150:443-449 (1990).
Mosnaim, et al., Clin. Chim. Acta, 46:407-413 (1973).
Mosnaim, et al., Biol. Psychiat., 8:227-234 (1974).
Sabelli, et al., J. Clin. Psych., 47:66-70 (1986).
Sabelli, et al., J. Clin. Psychopharmacol., 3:268-270 (1983).
Sandler, et al., Clin. Chim. Acta, 93:169-171 (1979).
Gray, Time, Feb. 15, 1993, pp. 47-51.
Birkmayer, et al., J. Neural Transmission, 59:81-87 (1984).
Moja et al., Biol. Psych., 11, 731-42 (1976).
Yang and Neff, J. Pharmacol. Exptl. Therap., 187:365-371 (1973).
Sabelli et al., "Phenylalanine Metabolism in Panic and Other Psychiatric Disorders," Presentation at VII World Congress of Psychiatry, Athens, Greece (Sep. 1989).
Adrenergic Neuron Blocking Agents, The Pharmacological Basis of Therapeutics, 7th Ed., Ch. 9, pp.204-210 (1985).
Baldessarini, Drugs and The Treatment of Psychiatric Disorders, The Pharmacological Basis of Therapeutics, 7th Ed., Ch. 19, pp. 391-447 (1985).
Bianchine, Drugs For Parkinson's Disease; Centrally Acting Muscle Relaxants, The Pharmacological Basis of Therapeutics, 7th Ed., Ch. 21, pp. 475-493 (1985).
Weiner, Norepinephrine, Epinephrine, and the Sympathomimetic Amines, The Pharmacological Basis of Therapeutics, 7th Ed., Ch. 8, pp. 138-175 (1985).
Cintins Marianne M.
Jarvis William R. A.
LandOfFree
Method for treating depression does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating depression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating depression will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1077845